Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06543472
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-04
Brief Title:
Dural Arteriovenous Fistulas Research at China INI
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Dural Arteriovenous Fistulas Research at China INI
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Dural arteriovenous fistula DAVF refers to abnormal connections between meningeal arteries and dural venous sinuses andor subarachnoid veins DAVF accounts for approximately 10 to 15 of intracranial vascular malformations With advancements in imaging technology increased awareness among physicians and an aging population the incidence of DAVF appears to be on the rise Some literature even suggests it may surpass the occurrence of arteriovenous malformations Several large-scale retrospective studies have been conducted internationally involving over 1000 cases but some of their findings differ from what is commonly understood Currently there is a lack of large-sample single-center studies on DAVF highlighting the urgent need for such research
Detailed Description:
TitleDural Arteriovenous Fistulas Research at China INI
PurposeThe incidence of DAVF is low By collecting clinical data we aim to establish a comprehensive database and biobank This will help us elucidate the potential pathogenesis vascular architecture biological markers and treatment outcomes of DAVFs Furthermore this study aims to address current controversies such as treatment strategies for DAVF with pial arterial supply unresolved issues such as the optimal treatment and prognosis of infantile type DAVF and further explore possible mechanisms of DAVF development
PurposeThe incidence of DAVF is low By collecting clinical data we aim to establish a comprehensive database and biobank This will help us elucidate the potential pathogenesis vascular architecture biological markers and treatment outcomes of DAVFs Furthermore this study aims to address current controversies such as treatment strategies for DAVF with pial arterial supply unresolved issues such as the optimal treatment and prognosis of infantile type DAVF and further explore possible mechanisms of DAVF development
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None